Detailed information for compound 266977

Basic information

Technical information
  • TDR Targets ID: 266977
  • Name: 5,6-dimethyl-2-[3-(4-naphthalen-1-ylpiperazin -1-yl)propylsulfanyl]-3H-thieno[2,3-d]pyrimid in-4-one
  • MW: 464.646 | Formula: C25H28N4OS2
  • H donors: 1 H acceptors: 3 LogP: 6.38 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Oc1nc(SCCCN2CCN(CC2)c2cccc3c2cccc3)nc2c1c(C)c(s2)C
  • InChi: 1S/C25H28N4OS2/c1-17-18(2)32-24-22(17)23(30)26-25(27-24)31-16-6-11-28-12-14-29(15-13-28)21-10-5-8-19-7-3-4-9-20(19)21/h3-5,7-10H,6,11-16H2,1-2H3,(H,26,27,30)
  • InChiKey: PPNYEQDFKJTXGT-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 5,6-dimethyl-2-[3-[4-(1-naphthyl)piperazin-1-yl]propylsulfanyl]-3H-thieno[2,3-d]pyrimidin-4-one
  • 5,6-dimethyl-2-[3-[4-(1-naphthalenyl)-1-piperazinyl]propylthio]-3H-thieno[2,3-d]pyrimidin-4-one
  • 5,6-dimethyl-2-[3-[4-(1-naphthyl)piperazino]propylthio]-3H-thieno[2,3-d]pyrimidin-4-one
  • 5,6-dimethyl-2-[3-(4-naphthalen-1-ylpiperazin-1-yl)propylsulfanyl]-3H-thieno[3,2-e]pyrimidin-4-one
  • 5,6-dimethyl-2-[3-[4-(1-naphthyl)piperazin-1-yl]propylsulfanyl]-3H-thieno[3,2-e]pyrimidin-4-one
  • 5,6-dimethyl-2-[3-[4-(1-naphthyl)-1-piperazinyl]propylthio]-3H-thieno[3,2-e]pyrimidin-4-one
  • 5,6-dimethyl-2-[3-[4-(1-naphthyl)piperazin-1-yl]propylthio]-3H-thieno[3,2-e]pyrimidin-4-one

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Serotonin 1a (5-HT1a) receptor Starlite/ChEMBL References
Rattus norvegicus Adrenergic receptor alpha-1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum expressed protein Get druggable targets OG5_133249 All targets in OG5_133249
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_133249 All targets in OG5_133249
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma japonicum ko:K04153 5-hydroxytryptamine (serotonin) receptor 1A, putative Get druggable targets OG5_133249 All targets in OG5_133249
Echinococcus granulosus biogenic amine 5HT receptor Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma mansoni biogenic amine (5HT) receptor Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma japonicum Octopamine receptor, putative Get druggable targets OG5_133249 All targets in OG5_133249
Echinococcus multilocularis serotonin receptor Get druggable targets OG5_133249 All targets in OG5_133249
Echinococcus multilocularis serotonin receptor Get druggable targets OG5_133249 All targets in OG5_133249
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Onchocerca volvulus Serotonin 1a (5-HT1a) receptor   422 aa 436 aa 23.9 %
Echinococcus multilocularis orexin receptor type 2 Serotonin 1a (5-HT1a) receptor   422 aa 369 aa 22.2 %
Loa Loa (eye worm) TYRA-2 protein Serotonin 1a (5-HT1a) receptor   422 aa 491 aa 27.3 %
Schistosoma japonicum ko:K04136 adrenergic receptor, alpha 1b, putative Serotonin 1a (5-HT1a) receptor   422 aa 444 aa 29.3 %
Echinococcus granulosus g protein coupled receptor Serotonin 1a (5-HT1a) receptor   422 aa 432 aa 23.4 %
Schistosoma mansoni peptide (FMRFamide/neurokinin-3)-like receptor Serotonin 1a (5-HT1a) receptor   422 aa 350 aa 20.6 %
Echinococcus multilocularis g protein coupled receptor Serotonin 1a (5-HT1a) receptor   422 aa 433 aa 22.4 %
Schistosoma mansoni amine GPCR Serotonin 1a (5-HT1a) receptor   422 aa 440 aa 31.6 %
Onchocerca volvulus Serotonin 1a (5-HT1a) receptor   422 aa 390 aa 33.6 %
Schistosoma japonicum ko:K04145 dopamine receptor D2, putative Serotonin 1a (5-HT1a) receptor   422 aa 410 aa 27.8 %
Echinococcus multilocularis neuropeptides capa receptor Serotonin 1a (5-HT1a) receptor   422 aa 430 aa 20.0 %
Schistosoma japonicum IPR000276,Rhodopsin-like GPCR superfamily,domain-containing Serotonin 1a (5-HT1a) receptor   422 aa 417 aa 21.1 %
Schistosoma japonicum IPR000276,Rhodopsin-like GPCR superfamily,domain-containing Serotonin 1a (5-HT1a) receptor   422 aa 392 aa 20.7 %
Onchocerca volvulus Serotonin 1a (5-HT1a) receptor   422 aa 407 aa 23.3 %
Echinococcus multilocularis g protein coupled receptor Serotonin 1a (5-HT1a) receptor   422 aa 432 aa 23.6 %
Onchocerca volvulus Mitochondrial inner membrane protein homolog Serotonin 1a (5-HT1a) receptor   422 aa 383 aa 30.5 %
Echinococcus granulosus g protein coupled receptor Serotonin 1a (5-HT1a) receptor   422 aa 432 aa 24.3 %
Onchocerca volvulus Serotonin 1a (5-HT1a) receptor   422 aa 426 aa 29.6 %
Echinococcus granulosus orexin receptor type 2 Serotonin 1a (5-HT1a) receptor   422 aa 369 aa 22.0 %
Schistosoma japonicum Octopamine receptor 1, putative Serotonin 1a (5-HT1a) receptor   422 aa 424 aa 24.3 %
Schistosoma japonicum ko:K04207 neuropeptide Y receptor Y5, putative Serotonin 1a (5-HT1a) receptor   422 aa 339 aa 23.0 %
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Serotonin 1a (5-HT1a) receptor   422 aa 448 aa 29.7 %
Loa Loa (eye worm) hypothetical protein Serotonin 1a (5-HT1a) receptor   422 aa 388 aa 26.5 %
Onchocerca volvulus Glycoprotein hormone beta 5 homolog Serotonin 1a (5-HT1a) receptor   422 aa 477 aa 24.3 %
Echinococcus granulosus alpha 1A adrenergic receptor Serotonin 1a (5-HT1a) receptor   422 aa 452 aa 21.0 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Wolbachia endosymbiont of Brugia malayi 1-acyl-sn-glycerol-3-phosphate acyltransferase 0.0169 1 0.5
Loa Loa (eye worm) acyltransferase 0.0169 1 1
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.014 0.8064 0.7937
Schistosoma mansoni 1-acyl-sn-glycerol-3-phosphate o-acyltransferase 0.0169 1 1
Loa Loa (eye worm) hypothetical protein 0.0156 0.9112 0.9053
Brugia malayi hypothetical protein 0.0027 0.062 0.062
Mycobacterium ulcerans 1-acylglycerol-3-phosphate O-acyltransferase 0.0169 1 0.5
Brugia malayi RNA recognition motif domain containing protein 0.014 0.8064 0.8064
Echinococcus multilocularis 1 acyl sn glycerol 3 phosphate acyltransferase 0.0169 1 1
Toxoplasma gondii acyltransferase domain-containing protein 0.0169 1 1
Echinococcus granulosus biogenic amine 5HT receptor 0.0156 0.9112 0.541
Chlamydia trachomatis glycerol-3-phosphate acyltransferase 0.0169 1 0.5
Echinococcus granulosus Phospholipid glycerol acyltransferase 0.0169 1 1
Treponema pallidum lysophosphatidic acid acyltransferase 0.0169 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0156 0.9112 0.9053
Echinococcus multilocularis serotonin receptor 0.0156 0.9112 0.541
Echinococcus multilocularis homeobox 0.0162 0.9543 0.7638
Echinococcus multilocularis 1 acyl sn glycerol 3 phosphate acyltransferase 0.0169 1 1
Mycobacterium ulcerans bifunctional transmembrane phospholipid biosynthesis enzyme PlsC 0.0169 1 0.5
Plasmodium falciparum 1-acyl-sn-glycerol-3-phosphate acyltransferase, putative 0.0169 1 1
Loa Loa (eye worm) hypothetical protein 0.0169 1 1
Loa Loa (eye worm) TAR-binding protein 0.014 0.8064 0.7937
Trypanosoma brucei 1-acyl-sn-glycerol-3-phosphate acyltransferase, putative 0.0169 1 1
Loa Loa (eye worm) hypothetical protein 0.0169 1 1
Mycobacterium leprae POSSIBLE TRANSMEMBRANE PHOSPHOLIPID BIOSYNTHESIS BIFUNCTIONAL ENZYME PLSC: PUTATIVE L-3-PHOSPHOSERINE PHOSPHATASE (O-PHOSPHOSERI 0.0169 1 0.5
Echinococcus multilocularis Phospholipid glycerol acyltransferase 0.0169 1 1
Echinococcus granulosus 1 acyl sn glycerol 3 phosphate acyltransferase 0.0169 1 1
Loa Loa (eye worm) RNA binding protein 0.014 0.8064 0.7937
Trypanosoma cruzi 1-acyl-sn-glycerol-3-phosphate acyltransferase, putative 0.0169 1 1
Echinococcus granulosus 1 acyl sn glycerol 3 phosphate acyltransferase 0.0169 1 1
Schistosoma mansoni transcription factor 0.0162 0.9543 0.7638
Loa Loa (eye worm) hypothetical protein 0.0162 0.9543 0.9513
Echinococcus granulosus Msx-like 0.0162 0.9543 0.7638
Mycobacterium tuberculosis 1-acylglycerol-3-phosphate O-acyltransferase 0.0169 1 1
Plasmodium vivax 1-acyl-sn-glycerol-3-phosphate acyltransferase, putative 0.0169 1 1
Leishmania major 1-acyl-sn-glycerol-3-phosphateacyltransferase-like protein, putative 0.0169 1 1
Toxoplasma gondii acyltransferase domain-containing protein 0.0169 1 1
Schistosoma mansoni biogenic amine (5HT) receptor 0.0156 0.9112 0.541
Brugia malayi RNA binding protein 0.014 0.8064 0.8064
Brugia malayi TAR-binding protein 0.014 0.8064 0.8064
Echinococcus multilocularis serotonin receptor 0.0156 0.9112 0.541

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 355 nM In vitro inhibitory concentration against radioligand [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane. ChEMBL. 9046348
IC50 (binding) = 355 nM In vitro inhibitory concentration against radioligand [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane. ChEMBL. 9046348
IC50 (binding) = 886 nM In vitro inhibitory concentration against radioligand [3H]-prazosin binding to alpha-1 adrenergic receptor in rat cortical membrane. ChEMBL. 9046348
IC50 (binding) = 886 nM In vitro inhibitory concentration against radioligand [3H]-prazosin binding to alpha-1 adrenergic receptor in rat cortical membrane. ChEMBL. 9046348
Selectivity (binding) = 2.5 Selectivity for alpha1-adrenergic receptor to that of 5-HT1A receptor. ChEMBL. 9046348

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.